About
Section 32 is a venture capital fund investing at the frontiers of technology and healthcare. Founded by Bill Maris, the team has vast experience building iconic companies. Our goal is to improve the human condition by accelerating the discovery, development and distribution of important technologies and life saving medicines. We invest across the entirety of technology and healthcare. This includes software, cybersecurity, advanced communications and computation, space, climate change related technologies, machine learning, artificial intelligence, biotechnology, therapeutics, advanced diagnostics, precision medicine, genomics and more.
Sector Focus
Healthcare
Genomics
Cancer
Tumor Detection
DNA
Liquid Biopsy
Blood
AI
Oncology
Pharmaceutical
Series Focus
Seed
Series A
Series B
Cheque Size
$4.0M - $110.0M
Score Breakdown
47Deal Activity
50Track Record
20Visibility
15Profile
100Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What type of investor is Section 32?
Section 32 is a venture capital fund investing at the frontiers of technology and healthcare. Founded by Bill Maris, the team has vast experience building iconic companies. Our goal is to improve the human condition by accelerating the discovery, development and distribution of important technologies and life saving medicines. We invest across the entirety of technology and healthcare. This includ…
What kind of firm is Section 32?
Section 32 is a Venture Capital.
What is Section 32's assets under management?
Section 32 manages approximately $1.5B in assets.
What sectors does Section 32 focus on?
Section 32 focuses on Healthcare, Genomics, Cancer, Tumor Detection.
Similar Investors